Medicamen Biotech Ltd signs distribution agreement with XGX Pharma, Denmark for 3 products

Medicamen Biotech Limited is pleased to announce signing of Distribution Agreement for following 3 products in European Market with XGX Pharma, Denmark.

Medicamen will hold the Marketing Authorization of these products. Two products out of three are of oncology and one product is Beta-lactam.

Oncology:

- Temozolamide capsules 250 mg
- Bortozemib 3.5mg inj x1vial

Beta-lactam:
- Amoxicillin, oral dispersible tablets 250 mg

Shares of MEDICAMEN BIOTECH LTD. was last trading in BSE at Rs. 492.50 as compared to the previous close of Rs. 460.70. The total number of shares traded during the day was 6515 in over 488 trades.

The stock hit an intraday high of Rs. 510.00 and intraday low of 462.50. The net turnover during the day was Rs. 3233316.00.

Source : Equity Bulls

Keywords

MEDICAMENBIOTECH INE646B01010 Pharmaceuticals DistributionAgreement XGXPharma Denmark